Drug Research

Protein Drug Manufacturing May Get New Purification Method

In a recent study, researchers at the Massachusetts Institute of Technology (MIT) have come up with a new purification approach to reduce the cost of making protein drugs. So as to isolate proteins from a bioreactor rapidly and cheaply,...

IAVI, BARDA Expand Partnership to Advance Filovirus Vaccine Candidates

International AIDS Vaccine Initiative (IAVI) announced the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, funded additional development and testing of IAVI's...

NIIMBL Unveils 3 New Vaccine Manufacturing Projects

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced approximately $1.7 million in planned project activities through the Institute's Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro...

AtomVie Builds Radiopharmaceutical CDMO Facility

AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high volume clinical and commercial GMP manufacturing and worldwide distribution of...

Novo Nordisk to Expand R&D Presence in Greater Boston Area

Novo Nordisk plans to expand its R&D presence in the greater Boston area, creating one of its largest R&D hubs outside of Denmark. The new hub, which will leverage the company’s existing presence in Lexington, Cambridge and Watertown, MA,...

Actylis Opens API Manufacturing Facility

Actylis, a global manufacturer of raw materials and performance ingredients for the life sciences and specialty chemicals markets, has opened a new 30,000 square foot cGMP facility in Eugene, OR. The multi-million dollar construction commenced in February of 2021...

AtomVie Builds Radiopharmaceutical CDMO Facility

AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high volume clinical and commercial GMP manufacturing and worldwide distribution of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read